Prolong Pharma 
Welcome,         Profile    Billing    Logout  
 3 Products   1 Disease  3 Products   3 Trials   77 News 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
EPEG (pegylated recombinant erythropoietin) / Cadila, Prolong Pharma
ACTRN12613000374763: A Phase 1 Single Blind, Randomized, Single-Dose, Safety, Tolerability, Pharmacodynamic, and Pharmacokinetic Study of ZY7318 (pegylated recombinant human erythropoietin) in Healthy Volunteers

Recruiting
1
32
 
Prolong Pharmaceuticals, LLC, Prolong Pharmaceuticals, LLC
Healthy volunteers study and investigational product would be targeted for secondary anemia due to renal cause.
 
 
ANF-Rho (pegfilgrastim biosimilar) / Prolong Pharma
2016-004539-18: Study of the efficacy, safety, tolerability and drug blood levlrs of ANF-RHO to treat patients with low white blood cells count portant sur l’efficacité, la sécurité d’emploi, la tolérabilité et la pharmacocinétique d’ANF–Rho™ chez les patients souffrant d'une baisse de nombre de globules blanches.

Ongoing
2
10
Europe
ANF RhoTM (pegfilgrastim ANF), ANF RhoTM, Solution for injection
Prolong Pharmaceuticals, LLC, Prolong Pharmaceuticals, LLC
Chronic neutropenia Neutropénie chronique, chronic decrease of white blood cells Baisse chronique des globules blanches, Diseases [C] - Blood and lymphatic diseases [C15]
 
 
Sanguinate (PEGylated Carboxyhemoglobin bovine) / Prolong Pharma
HEMERA-1, NCT04677777: Safety Study of PP-007 in Subjects With Acute Ischemic Stroke

Recruiting
1
24
US
PP-007 (Two doses administered 24±6 hours apart) + SOC (IVT or MT or IVT+MT), Sanguinate
Prolong Pharmaceuticals
Acute Ischemic Stroke
12/24
02/25
ChiCTR2000032687: A split-mouth randomized controlled clinical study of applying CGF to repair distal bone defect of mandibular second molar after the extraction of impacted mandibular third molar

Not yet recruiting
N/A
50
 
Exsanguinate the patient's own blood to prepare for CGF and then put CGF into distal side of mandibular second molar in the operating area after the extraction of fully-impacted mandibular third molar. ;Directly suture the wound after the extraction of fully-impacted mandibular third molar.
Oral and Maxillofacial Surgery, the Affiliated Stomatology of Tongji University; The Affiliated Stomatology of Tongji University, Oral and Maxillofacial Surgery,the Affiliated Stomatology of Tongji University
Fully-impacted mandibular third molar
 
 
ChiCTR2300077819: A clinical study of effect of CGF combined with autogenous bone on distal periodpntal tissue regeneration of mandibular second molar after extraction of impacted mandibular third molar

Recruiting
N/A
180
 
Exsanguinate the patient's own blood to prepare for CGF and then put CGF into the extracion socket of mandibular second molar in the operating area after the extraction of fully-impacted mandibular third molar.; Directly suture the wound after the extraction of impacted mandibular third molar.
Department of Stomatology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University; Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Department of Stomatology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University
Impacted mandibular third molar
 
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
EPEG (pegylated recombinant erythropoietin) / Cadila, Prolong Pharma
ACTRN12613000374763: A Phase 1 Single Blind, Randomized, Single-Dose, Safety, Tolerability, Pharmacodynamic, and Pharmacokinetic Study of ZY7318 (pegylated recombinant human erythropoietin) in Healthy Volunteers

Recruiting
1
32
 
Prolong Pharmaceuticals, LLC, Prolong Pharmaceuticals, LLC
Healthy volunteers study and investigational product would be targeted for secondary anemia due to renal cause.
 
 
ANF-Rho (pegfilgrastim biosimilar) / Prolong Pharma
2016-004539-18: Study of the efficacy, safety, tolerability and drug blood levlrs of ANF-RHO to treat patients with low white blood cells count portant sur l’efficacité, la sécurité d’emploi, la tolérabilité et la pharmacocinétique d’ANF–Rho™ chez les patients souffrant d'une baisse de nombre de globules blanches.

Ongoing
2
10
Europe
ANF RhoTM (pegfilgrastim ANF), ANF RhoTM, Solution for injection
Prolong Pharmaceuticals, LLC, Prolong Pharmaceuticals, LLC
Chronic neutropenia Neutropénie chronique, chronic decrease of white blood cells Baisse chronique des globules blanches, Diseases [C] - Blood and lymphatic diseases [C15]
 
 
Sanguinate (PEGylated Carboxyhemoglobin bovine) / Prolong Pharma
HEMERA-1, NCT04677777: Safety Study of PP-007 in Subjects With Acute Ischemic Stroke

Recruiting
1
24
US
PP-007 (Two doses administered 24±6 hours apart) + SOC (IVT or MT or IVT+MT), Sanguinate
Prolong Pharmaceuticals
Acute Ischemic Stroke
12/24
02/25
ChiCTR2000032687: A split-mouth randomized controlled clinical study of applying CGF to repair distal bone defect of mandibular second molar after the extraction of impacted mandibular third molar

Not yet recruiting
N/A
50
 
Exsanguinate the patient's own blood to prepare for CGF and then put CGF into distal side of mandibular second molar in the operating area after the extraction of fully-impacted mandibular third molar. ;Directly suture the wound after the extraction of fully-impacted mandibular third molar.
Oral and Maxillofacial Surgery, the Affiliated Stomatology of Tongji University; The Affiliated Stomatology of Tongji University, Oral and Maxillofacial Surgery,the Affiliated Stomatology of Tongji University
Fully-impacted mandibular third molar
 
 
ChiCTR2300077819: A clinical study of effect of CGF combined with autogenous bone on distal periodpntal tissue regeneration of mandibular second molar after extraction of impacted mandibular third molar

Recruiting
N/A
180
 
Exsanguinate the patient's own blood to prepare for CGF and then put CGF into the extracion socket of mandibular second molar in the operating area after the extraction of fully-impacted mandibular third molar.; Directly suture the wound after the extraction of impacted mandibular third molar.
Department of Stomatology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University; Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Department of Stomatology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University
Impacted mandibular third molar
 
 

Download Options